Healthcare stocks were softer late Friday afternoon, with the NYSE Healthcare Index 0.1% lower and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3%.
The iShares Biotechnology ETF (IBB) was fractionally lower.
In corporate news, Xencor (XNCR) shares jumped 11% after the firm said Friday that phase 1 results for its experimental cancer therapy XmAb819 in advanced clear cell renal cell carcinoma have been selected for a proffered paper oral presentation at the European Society of Medical Oncology Congress in October.